Menu Search
Equities

Nova Leap Health Corp

NVLPF:QXE

Nova Leap Health Corp

Actions
  • Price (USD)0.2164
  • Today's Change-0.034 / -13.42%
  • Shares traded79.50k
  • 1 Year change+96.76%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 19:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Nova Leap Health Corp was unable to grow net income despite reducing the cost of goods sold, selling, general and administrative expenses and interest paid (all as a percentage of sales). In part this was due to revenues that fell from 28.21m to 26.18m.
Gross margin38.56%
Net profit margin-1.80%
Operating margin-1.29%
Return on assets-2.15%
Return on equity-2.49%
Return on investment-2.38%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Nova Leap Health Corp fell by 377.88k. However, the company earned 2.15m from its operations for a Cash Flow Margin of 8.23%. In addition the company used 23.13k on investing activities and also paid 2.52m in financing cash flows.
Cash flow per share0.0026
Price/Cash flow per share118.36
Book value per share0.2967
Tangible book value per share0.0512
More ▼

Balance sheet in USDView more

Nova Leap Health Corp has a Debt to Total Capital ratio of 6.07%, a higher figure than the previous year's 5.69%.
Current ratio1.76
Quick ratio--
Total debt/total equity0.0646
Total debt/total capital0.0607
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.